New Zealand markets open in 8 hours 20 minutes

Genflow Biosciences plc (GENF.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
2.2200-0.0300 (-1.33%)
As of 01:41PM BST. Market open.
Currency in GBp

Valuation measures4

Market cap (intra-day) 7.87M
Enterprise value 7.18M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)10.84
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.56

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-19.64%
S&P500 52-week change 327.84%
52-week high 33.9000
52-week low 31.3230
50-day moving average 31.7204
200-day moving average 31.7355

Share statistics

Avg vol (3-month) 31.01M
Avg vol (10-day) 31.3M
Shares outstanding 5349.71M
Implied shares outstanding 6349.71M
Float 8132.6M
% held by insiders 163.87%
% held by institutions 19.15%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)519.04%

Management effectiveness

Return on assets (ttm)-55.19%
Return on equity (ttm)-105.34%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -1.63M
Net income avi to common (ttm)-1.63M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)683.97k
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)3.09
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-1.66M
Levered free cash flow (ttm)-1.05M